Patent Application
Utility
PCT National Stage
App. No. 17/638,744
· Confirmation No. 3171
PYRIDO-INDOLE ANALOGUES AS GPX4 INHIBITORS
Inventors:
Anjali Pandey, Chun Jiang, Ruihong Chen, Biswajit Kalita, Athisayamani Jeyaraj Duraiswamy
Applicant:
Ferro Therapeutics, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-09-15 | ABN |
Abandonment | 2 | View | |
| 2025-07-11 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-07-11 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-02-11 | NRES |
Letter Restarting Period for Response (i.e. Letter re: References) | 16 | View | |
| 2025-02-11 | 892 |
List of references cited by examiner | 1 | View | |
| 2025-02-11 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2025-02-11 | SRNT |
Examiner's search strategy and results | 8 | View | |
| 2025-02-11 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2025-02-11 | 1449 |
List of References cited by applicant and considered by examiner | 2 | View | |
| 2025-02-11 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2025-02-11 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2025-02-11 | SRNT |
Examiner's search strategy and results | 5 | View | |
| 2024-12-10 | CTNF |
Non-Final Rejection | 15 | View | |
| 2024-12-10 | 892 |
List of references cited by examiner | 1 | View | |
| 2024-12-10 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2024-12-10 | 1449 |
List of References cited by applicant and considered by examiner | 2 | View | |
| 2024-12-10 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2024-12-10 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2022-11-15 | M903 |
Notice of Designated Office (DO) / Elected Office (EO) Acceptance Mailed | 2 | View | |
| 2022-11-15 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2022-11-15 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-11-15 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-11-07 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-11-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-11-07 | A.PE |
Preliminary Amendment | 1 | View | |
| 2022-11-07 | CLM |
Claims | 40 | View | |
| 2022-11-07 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2022-07-21 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2022-04-15 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-04-08 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2022-04-08 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-04-08 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-04-08 | 371.FEE.M923 |
371 (National Stage) Supplemental Fees Missing - Form M923 | 2 | View | |
| 2022-04-06 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-02-25 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 2 | View | |
| 2022-02-25 | FOR |
Foreign Reference | 19 | View | |
| 2022-02-25 | FOR |
Foreign Reference | 86 | View | |
| 2022-02-25 | FOR |
Foreign Reference | 216 | View | |
| 2022-02-25 | FOR |
Foreign Reference | 75 | View | |
| 2022-02-25 | FOR |
Foreign Reference | 288 | View | |
| 2022-02-25 | FOR |
Foreign Reference | 68 | View | |
| 2022-02-25 | FOR |
Foreign Reference | 193 | View | |
| 2022-02-25 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 23 | View | |
| 2022-02-25 | 371P |
Documents submitted with 371 (National Stage) Applications | 164 | View | |
| 2022-02-25 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-02-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 5 | View | |
| 2022-02-25 | TRNA |
Transmittal of New Application | 4 | View | |
| 2022-02-25 | ADS |
Application Data Sheet | 7 | View | |
| 2022-02-25 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2022-02-25 | A.PE |
Preliminary Amendment | 1 | View | |
| 2022-02-25 | SPEC |
Specification | 1 | View | |
| 2022-02-25 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2022-02-25 | CLM |
Claims | 15 | View | |
| 2022-02-25 | SPEC |
Specification | 147 | View | |
| 2022-02-25 | ABST |
Abstract | 1 | View | |
| 2022-02-25 | ABST |
Abstract | 1 | View | |
| 2022-02-25 | FRPR |
Certified Copy of Foreign Priority Application | 75 | View | |
| 2022-02-25 | P.N.101.CONV |
PCT/RO/101 - Request form for new International Application - Conventional | 4 | View | |
| 2022-02-25 | 371P |
Documents submitted with 371 (National Stage) Applications | 2 | View | |
| 2022-02-25 | FRPR |
Certified Copy of Foreign Priority Application | 103 | View |
Inventors
Anjali Pandey
Fremont, CA
Chun Jiang
Hillsborough, CA
Ruihong Chen
Burlingame, CA
Biswajit Kalita
Bangalore, INDIA
Athisayamani Jeyaraj Duraiswamy
Bangalore, INDIA
Attorneys & Agents of Record
Classification
USPC
514/253.03
C07D471/04
A61P35/00
A61K31/437
A61K31/4375
A61K31/496
A61K45/06
C07D519/00
Prosecution
- Examiner
- YOUNGBLOOD, WILLIAM JUSTIN
- Art Unit
- 1629
- Customer No.
- 117795
- Docket No.
- 66EW-300742-US
- Confirmation No.
- 3171
Publication
- Pub. No.
- US20220227765A1
- Pub. Date
- 2022-07-21
Parent
PCT
is a National Stage Entry of
→
PCT/US2020/047993
Filed 2020-08-26
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 62/893,137
Filed 2019-08-28
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/893,128
Filed 2019-08-28
· Provisional Application Expired
Child
is a Continuation of
→
App. 19/267,260
Filed 2025-07-11
· Abandoned -- Incomplete Application (Pre-examination)
BRIDGEBIO PHARMA, INC.,
QED THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
CALCILYTIX THERAPEUTICS INC.,
ADRENAS THERAPEUTICS INC.,
PHOENIX TISSUE REPAIR, INC.,
NAVIRE PHARMA, INC.,
VENTHERA, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
PORTAL THERAPEUTICS, INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
FERRO THERAPEUTICS, INC.
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL
Recorded 2025-03-05
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
BRIDGEBIO PHARMA, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
QED THERAPEUTICS, INC.,
SUB21, INC.,
THERAS, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-19
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
SUB21, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-17
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/638,744
- Filed
- 2022-02-25
- Pub. No.
- US20220227765A1
- Examiner
- YOUNGBLOOD, WILLIAM JUSTIN
- Art Unit
- 1629
External Links